ING4 and breast cancer: miR-650 expression altered through its complementary binding to the 3′-UTR of ING4 is found to be associated with numerous cancer types, including gastric, chronic lymphocytic leukemia, lung, hepatocellular, osteosarcoma, and breast cancers [89,92,155–158].